300
Participants
Start Date
October 31, 2010
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
AZD9773
A single loading dose following by up to 9 maintenance doses; doses to be given every 12 hours over a period of 5 days
Placebo
Placebo
Research Site, Blacktown
Research Site, Wollongong
Research Site, Herston
Research Site, Nambour
Research Site, Woollongabba
Research Site, Adelaide
Research Site, Clayton
Research Site, Footscray
Research Site, Fremantle
Research Site, Antwerp
Research Site, Brussels
Research Site, Genk
Research Site, Godinne
Research Site, Liège
Research Site, Ottignies
Research Site, Edmonton
Research Site, Vancouver
Research Site, Victoria
Research Site, Winnipeg
Research Site, Halifax
Research Site, Ottawa
Research Site, Windsor
Research Site, Québec
Research Site, Hradec Králové
Research Site, Prague
Research Site, Ústí nad Labem
Research Site, Kuopio
Research Site, Tampere
Research Site, Angers
Research Site, Dijon
Research Site, La Roche-sur-Yon
Research Site, Limoges
Research Site, Montauban
Research Site, Nantes
Research Site, Nîmes
Research Site, Orléans
Research Site, Paris
Research Site, Poitiers
Research Site, Saint-Michel
Research Site, Toulon
Research Site, Toulouse
Research Site, Tours
Research Site, Vandœuvre-lès-Nancy
Research Site, Palma de Mallorca
Research Site, Sabadell
Research Site, Barcelona
Research Site, Terrassa
Research Site, Santiago de Compostela
Research Site, Getafe
Research Site, Madrid
Research Site, Oviedo
Research Site, Valencia
Lead Sponsor
AstraZeneca
INDUSTRY